Pricing Log in Create free account

Aptevo Therapeutics Inc. (APVO) vs Eocene Ltd. (EOCN)

Aptevo Therapeutics Inc. and Eocene Ltd. are both Biotechnology companies. Aptevo Therapeutics Inc. and Eocene Ltd. are of similar size ($3.2M and $3.1M). Eocene Ltd. has negative trailing earnings, so its P/E is not meaningful; Aptevo Therapeutics Inc. trades at 0.0×. Aptevo Therapeutics Inc. grew revenue faster over the last twelve months: 92.9% against 87.8%. Across the 13 metrics below, Aptevo Therapeutics Inc. leads on 7 and Eocene Ltd. on 6.

Valuation

Metric APVO EOCN Biotechnology median
P/E 0.00 n/m 8.50
P/S 0.15 1.33 9.71
P/B 0.32 0.21 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.17 0.61 0.64
EV/Sales (0.34) (3.00) 9.21
Earnings yield 100,773.33% (532.63%) (33.15%)
Free cash flow yield (1,315.16%) (314.99%) (25.50%)

Profitability

Metric APVO EOCN Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (446.89%) (68.21%) (56.36%)
Return on assets (186.29%) (55.03%) (48.04%)
Return on invested capital 0.00% (163.19%) 0.00%

Growth

Metric APVO EOCN Biotechnology median
Revenue growth (TTM) 92.94% 87.83% 6.02%
EPS growth (last fiscal year) 99.72% 70.42% 30.26%
Revenue growth, 5-year CAGR (26.64%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric APVO EOCN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.08 4.16 4.72
Net debt to EBITDA 0.83 1.31 0.96

Dividend

Metric APVO EOCN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric APVO EOCN Biotechnology median
Market cap 3.08m 3.18m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack